Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(S)-ATPO (Synonyms: ATPO)

Catalog No. T3473 Copy Product Info
Purity: 99.41%
😃Good
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.

(S)-ATPO

Copy Product Info
😃Good
Catalog No. T3473
Synonyms ATPO

(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.

(S)-ATPO
Cas No. 252930-37-3
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$30In StockIn Stock
5 mg$59In StockIn Stock
10 mg$95In StockIn Stock
25 mg$181In StockIn Stock
50 mg$283In StockIn Stock
100 mg$413In StockIn Stock
1 mL x 10 mM (in DMSO)$73In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.41%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

(S)-ATPO AI Summary
(S)-ATPO shows diverse bioactivity across multiple targets. It functions as an inhibitor of the Ionotropic glutamate receptor AMPA, demonstrating IC50 values of 35,000 nM for [3H]AMPA binding and 5,700 nM for [3H]CNQX binding. It also inhibits AMPA-induced electrophysiological responses in rat cortical slices with an IC50 value of 28,000 nM, but does not significantly inhibit [3H]CPP binding to the NMDA receptor or [3H]KAIN binding to the Ionotropic glutamate receptor kainate (IC50 > 100,000 nM). Additionally, (S)-ATPO inhibits several enzymes and pathways: Cruzain (158.5 nM), Bloom's syndrome helicase (BLM) (79.4 nM), Histone Lysine Methyltransferase G9a in various assays (50,118.7 nM, 8,912.5 nM, 5,323.3 nM), Pin1 (37,933.0 nM), and Human Flap endonuclease 1 (FEN1) (8,436.8 nM). It also inhibits Plasmodium falciparum (17,782.8 nM), Marburg Virus binding/entry (16,353.5 nM), and Human Apurinic/apyrimidinic Endonuclease 1 (APE1) (50,118.7 nM). Moreover, it enhances Arylsulfatase A (ASA1) (4,256.2 nM and 67.5 nM in different assays) and identifies Gametocytocidal compounds (6,309.6 nM)..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
(S)-ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
SynonymsATPO
Chemical Properties
Molecular Weight322.25
FormulaC11H19N2O7P
Cas No.252930-37-3
SmilesCC(C)(C)c1onc(OCP(O)(O)=O)c1C[C@H](N)C(O)=O
Relative Density.1.443 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3.23 mg/mL (10.02 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1032 mL15.5159 mL31.0318 mL155.1590 mL
5 mM0.6206 mL3.1032 mL6.2064 mL31.0318 mL
10 mM0.3103 mL1.5516 mL3.1032 mL15.5159 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (S)-ATPO | purchase (S)-ATPO | (S)-ATPO cost | order (S)-ATPO | (S)-ATPO chemical structure | (S)-ATPO formula | (S)-ATPO molecular weight